Gastrointestinal ğnfections

devrim, ilker; Kurugöl, Zafer

Gastrointestinal ğnfections

Zafer KURUGÖL, (Ege Üniversitesi, Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İzmir, Türkiye)

İlker DEVRİM (Ege Üniversitesi, Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Hastanesi, İzmir, Türkiye)

Çocuk Enfeksiyon Dergisi

8 2

Yıl: 2014 Cilt: 8 Sayı: 2 Sayfa Aralığı: 71 - 81 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Gastrointestinal ğnfections

Öz:

İshalli hastalıklar bütün dünyada sağlık kurumlarına başvurunun en sık nedenleri arasında sayılmaktadır. Dünya genelinde yılda yaklaşık 2-3 milyar kişinin gastroenterite yakalandığı tahmin edilmektedir. Beş yaş altındaki çocukların yılda ortalama 3,2 kez ishal oldukları bildirilmiştir. Gastrointestinal infeksiyonlar hijyen koşullarının ve sağlık sisteminin geri olduğu, alt yapının ve besin sanitasyonunun yetersiz olduğu gelişmekte olan ülkelerde yaygın olarak görülmekte- dir. Akut gastroenterit (AGE) dışkı kıvamının yumuşa- ması ve/veya sıklığının artması (günde 3 veya daha fazla) olarak tanımlanır. Ateş veya kusma eşlik edebi- lir. İshal genel olarak 7 günden daha kısa sürer ve 14 günü aşmaz. Gastrointestinal sistem infeksiyonlarına virus, bakteri, protozoa, helmit ve mantarlar neden olur. Antibiyotik tedavisi bakterilere sekonder enterik bakteryel infeksiyonlarda belli endikasyon ve bakteri- ler için endikedir. Gastroenterit tedavisinde en önem- li basamak çocuğun sıvı ve elektrolit dengesini sağla- mak için rehidratasyon ve replasman tedavisidir. Birçok hastada oral rehidratasyon tedavisi yeterlidir.

Anahtar Kelime:

Konular: Temel Sağlık Hizmetleri

Gastrointestinal enfeksiyonlar

Öz:

Gastroenteritis is one of the most common reasons for physician visits worldwide. Annually, 2 or 3 billion people are estimated to suffer from gastroenteritis. Children under 5 years old are reported to experience gastroenteritis 3.2 times a year. Gastrointestinal infections are more prominent in geographic regions with poor sanitation and health systems. Acute gas- troenteritis is generally defined as a decrease in the consistency of stools (loose or liquid) and/or an increase in the frequency of evacuations (typically ≥3 in 24 h). Diarrhea typically lasts less than 7 days and not longer than 14 days. Viruses, bacteria, protozoa, helminths, and fungus cause gastrointestinal system infections. Antibiotic treatment is indicated only for bacterial enteric infections and indications. The most important step for treatment of gastroenteritis is rehy- dration and replacement therapy for restoring fluid and electrolyte balance. In most of the cases, oral rehydration therapy is adequate for the treatment.

Anahtar Kelime:

Konular: Temel Sağlık Hizmetleri

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1.Kosek M, Bern C, Guerrant RL. The global burden of diarrhoe- al disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81: 197-204.
2.King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional the- rapy. MMWR Recomm Rep 2003; 52: 1-16.
3.Guarino A, Albano F, Ashkenazi S, et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition; European Society for Paediatric Infectious Diseases. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guide- lines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008; 46: 81-122. [CrossRef]
4.Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analy- sis. Lancet 2010; 375: 1969-87. [CrossRef]
5.Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003; 361: 2226-34. [CrossRef]
6.Parashar U, Hummelman E, Bresee J, Miller M, Glass R. Global Ill- ness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9: 565-72. [CrossRef]
7. T.C. Sağlık Bakanlığı Refik Sydam Hıfzısıhha Merkez Başkanlığı (RSHMB). National Burden of Disease and Cost Effectiveness Project. Burden of Disease Final Report, Ankara (2004).
8. http://www.hips.hacettepe.edu.tr/tnsa2008/data/TNSA-2008_ ozet_Rapor-tr.pdf (Erişim Tarihi: 05.02.2014)
9. Bandres J, DuPont HL. Approach to the patient with diarrhoea. In: SL Gorbach, JG Bartlett, NR Blacklow. (Eds). Infectious Diseases, 2nd Ed. WB Saunders Company, Philadelphia USA, 1998.p.691-4.
10. Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI. Update on rotavirus vaccines. Pediatr Infect Dis J 2005; 24: 947-52. [CrossRef]
11. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in child- ren. Emerg Infect Dis 2003; 9: 565-72. [CrossRef]
12. Ficher TK, Vibaud C, Parashar U, et al. Hospitalizations and Deaths from Diarrhea and Rotavirus among Children _____5 Years of Age in the United States, 1993-2003. J Infect Dis 2007; 195: 1117-25. [CrossRef]
13. WHO. 5th Anual Global Immunization Meeting. February 2, 2010, Geneva, Switzerland.
14. Kurugöl Z, Geylani S, Karaca Y, et al. Rotavirus gastroenteritis among children under five years of age in İzmir, Turkey. Turk J Ped 2003; 45: 290-4.
15. Ceyhan M, Alhan E, Salman N, et al. Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study. J Infect Dis 2009; 200: 234-8. [CrossRef]
16. Ogilvie I, Khoury H, El Khoury AC, Goetghebeur MM. Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of ill- ness. Hum Vaccin 2011; 7 : 523-33. [CrossRef]
17. Amercan Academy of Pediatrics (Rotavirus). In: Pickerling LK, Baker CJ, Kimberlin DW, Long SS,eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Vllage, IL: American Academy of Pediatrics; 2009: p.576-9.
18. Amercan Academy of Pediatrics(Norovirus). In : Pickerling LK, Baker CJ, Kimberlin DW, Long SS,eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Vllage, IL: American Academy of Pediatrics; 2009: p. 241-2.
19. Goodgame RW. Viral causes of diarrhoea. Gastroenterol Clin N Am 2001; 30: 779-95. [CrossRef]
20. Midthun K, Black RE. Viral diarrheas. In: GT Strickland. (Ed.) Hunters Tropical Medicine and Emerging Infectious Diseases, 8th Ed. WB Saunders Company, Philadelphia USA, 2000: p.220-6.
21. Bresee JS, Widdowson MA, Monroe SS, Glass RI. Foodborne viral gastroenteritis: challenges and opportunities. Clin Infect Dis 2002; 35: 748-53. [CrossRef]
22. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607-25. [CrossRef]
23. Koo HL, Ajami N, Atmar RL, DuPont HL. Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med 2010; 10: 61-70.
24. Uyar Y, Carhan A, Ozkaya E, Ertek M. Evaluation of laboratory diagnosis of the first norovirus outbreak in Turkey in 2008. Mikrobiyol Bul 2008; 42: 607-15.
25. Altindis M, Bányai K, Kalayci R, et al. Frequency of norovirus in stool samples from hospitalized children due to acute gastro- enteritis in Anatolia, Turkey, 2006-2007. Scand J Infect Dis 2009; 41: 685-8. [CrossRef]
26. Walter JE, Mitchell DK. Astrovirus infection in children. Curr Opin Infect Dis 2003; 16: 247-53. [CrossRef]
27. Ozdemir S, Delialioğlu N, Emekdaş G. Investigation of rotavi- rus, adenovirus and astrovirus frequencies in children with acute gastroenteritis and evaluation of epidemiological featu- res. Mikrobiyol Bul 2010; 44: 571-8.
28. Wilhelmi I, Roman E, Sánchez-Fauquier A. Viruses causing gast- roenteritis. Clin Microbiol Infect 2003; 9: 247-62. [CrossRef]
29. King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional the- rapy. MMWR Recomm Rep 2003; 52: 1-16.
30. Duggan C, Lasche J, McCarty M, et al. Oral rehydration solu- tion for acute diarrhea prevents subsequent unscheduled follow-up visits. Pediatrics 1999; 104: e29. [CrossRef]
31. Sandhu BK. Practical guidelines for the management of gastroenteritis in children. J Pediatr Gastroenterol Nutr 2001; 33: 369. [CrossRef]
32. Hossain S, Biswas R, Kabir I, et al. Single dose vitamin A treat- ment in acute shigellosis in Bangladeshi children: randomized double blind controlled rial. BMJ 1998; 316: 4226. [CrossRef]
33. WHO/UNICEF Joint Statement:Clinical Managemet of Acute Diarrhae, May 2004.
34. Piescik-Lech M, Shamir R, Guarino A, Szajewska H. Review article: the management of acute gastroenteritis in children. Aliment Pharmacol Ther 2013; 37: 289-303. [CrossRef]
35. Guarino A, Albano F, Ashkenazi S, et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/ European Society for Paediatric Infectious Diseases evidence- based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr 2008; 46: 619-21.
36. Peng J, Yang J, Jin Q. Research progress in Shigella in the post- genomic era. Sci China Life Sci 2010; 53: 1284-90. [CrossRef]
37. Ahmed F, Clemens JD, Rao MR, Ansaruzzaman M, Haque E. Epidemiology of shigellosis among children exposed to cases of Shigella dysentery: a multivariate assessment. Am J Trop Med Hyg 1997; 56: 258-64.
38. Shears P. Shigella infections. Ann Trop Med Parasit 1996; 90: 105-14.
39. Keddy K, Goldsmid JM, Frean J. Tropical Gastrointestinal Infections. Australasian College of Tropical Medicine. Primer of tropical medicine 6.1-6.24 (Erişim Tarihi: 05.02.2014)
40. Niyogi SK. Shigellosis. J Microbiol 2005; 43: 133-43.
41. Motarjemi Y, Kaferstein F. Global estimation of foodborne diseases. Wld Hlth Statist Quart 1997; 50: 5-11
42. Torres AG. Current aspects of Shigella pathogenesis. Rev Latinoam Microbiol 2004; 46: 89-97.
43. Karacan C, Tavil B, Topal Y, Zorlu P, Tayman C. Evaluation of shigellosis in a Turkish children's hospital. Pediatr Int 2007; 49: 589-92. [CrossRef]
44. Wenneras C, Erling V. Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J Health Popul Nutr 2004; 22: 370-82.
45. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Micro Rev 1998; 11: 142-201.
46. Effler P, Isaäcson M, Arntzen L, et al. Factors contributing to the emergence of Escherichia coli O157 in Africa. Emerg Infect Dis 2001; 7: 812-9. [CrossRef]
47. Levine MM, Nataro JP. Diarrhea caused by Escherichia coli. In: GT Strickland. (Ed.) Hunters Tropical Medicine and Emerging Infectious Diseases, 8th Ed. WB Saunders Company, Philadelphia, USA, 2000: p.334-8.
48. Rendón MA, Saldaña Z, Erdem AL, et al. Commensal and pat- hogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci U S A 2007; 104: 10637-42. [CrossRef]
49. Pennington H. Escherichia coli O157. Lancet 2010; 376: 1428-35. [CrossRef]
50. World Health Organisation. Background document: the diag- nosis, treatment and prevention of typhoid fever. WHO, Geneva, 2003.
51. Kuşkonmaz B, Yurdakök K, Yalçin SS, Ozmert E. Comparison of acute bloody and watery diarrhea: a case control study. Turk J Pediatr 2009; 51: 133-40.
52. Erdem B, Hasçelik G, Gedikocğlu S, et al. Salmonella enterica serotypes and Salmonella infections: a multicenter study covering ten provinces in Turkey. Mikrobiyol Bul 2004; 38: 173-86.
53. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32: 263-9. [CrossRef]
54. Mason CJ, Longfield RN. Nontyphoidal Salmonella infections. In: GT Strickland. (Ed.) Hunters Tropical Medicine and Emerging Infectious Diseases, 8th Ed. WB Saunders Company, Philadelphia, USA, 2000: p. 484-91.
55. Hanes D. Nontyphoid Salmonella. In: MD Miliotis, JW Bier (Eds). International Handbook of Foodborne Pathogens. Marcel Dekker, New York, USA. 2003: p. 137-49. [CrossRef]
56. Graham SM, Walsh AL, Molyneux EM, Phiri AJ, Molyneux ME. Clinical presentation of non-typhoidal salmonellosis in Malawian children. Trans R Soc Trop Med Hyg 2000; 94: 310-4. [CrossRef]
57. Gordon MA, Banda HT, Gondwe M et al. Non-typhoidal salmonel- la bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002; 16: 1633-41. [CrossRef]
58. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002; 8: 237-43. [CrossRef]
59. Oberhelman R, Gilman RH, Sheen P et al. Campylobacter trans- mission in a Peruvian shantytown: a longitudinal study using strain typing of Campylobacter isolates from chickens and humans in household clusters. J Infect Dis 2003; 187: 260-9. [CrossRef]
60. Hu L, Kopecko DJ. Campylobacter species. In: MD Miliotis, JW Bier (Eds). International Handbook of Foodborne Pathogens. Marcel Dekker, New York, USA 2003: p. 181-98.
61. Uysal G, Doğru U, Aysev D, Karabiber N. Campylobacter jejuni gast- roenteritis in Turkish children. Infection 1997; 25: 159-62. [CrossRef]
62. Reidl J, Klose KE. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev 2002; 26: 125-39. [CrossRef]
63. Cholera vaccines. A brief summary of the March 2010 position paper" (PDF). World Health Organization.
64. Shears P. Cholera. Ann Trop Med Parasit 1994; 88: 109-22.
65. Bennish ML. Cholera: pathophysiology, clinical features, and treatment. In: Vibrio cholerae and Cholera: Molecular to Global Perspectives (Wachsmuth KI., Blake PA and Olsik O Eds.). American Society for Microbiology, Washington, DC. 1994, p. 229-55. [CrossRef]
66. Fishmann PH. Mechanism of action of cholera toxin. In: ADP- ribosylating Toxins and G Proteins (Moss J and Vaughan M, Eds.) American Society for Microbiology, Washington, DC. 1990.p.127-37.
67. King CA, van Heyningen WA. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside. J Infect Dis 1973; 127: 639-47. [CrossRef]
68. Pierce NF. Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli. J Exp Med 1973; 137: 1009-23. [CrossRef]
69. Chua AL, Elina HT, Lim BH, Yean CY, Ravichandran M, Lalitha P. Development of a dry reagent-based triplex PCR for the detection of toxigenic and non-toxigenic Vibrio cholerae. J Med Microbiol 2011; 60: 481-5. [CrossRef]
70. Mukherjee P, Ghosh S, Ramamurthy T, et al. Evaluation of a rapid immunochromatographic dipstick kit for diagnosis of cholera emphasizes its outbreak utility. Jpn J Infect Dis 2010; 63: 234-8.
71. Rendón MA, Saldaña Z, Erdem AL, et al. Commensal and pat- hogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci USA 2007; 104: 10637-42. [CrossRef]
72. Olopoenia LA, King AL. Widal agglutination test - 100 years later: still plagued by controversy. Postgrad Med J 2000; 76: 80-4. [CrossRef]
73. Wain J, Hosoglu S. The laboratory diagnosis of enteric fever. J Infect Dev Ctries 2008; 2: 421-5.
74. Devrim I, Ergunay K, Kara A, et al. The comparison of cultu- res, widal agglutination test and polymerase chain reaction as a diagnostic tool in typhoid fever. Centr Eur J Med 2008; 3: 470-4. [CrossRef]
75. Traa BS, Walker CL, Munos M, Black RE. Antibiotics for the treatment of dysentery in children. Int J Epidemiol 2010; 39: 70-4. [CrossRef]
76. Materu SF, Lemu OE, Mukunza HM, Dhiambo CG, Carter JY. Antibiotic resistance patterns of Vibrio cholerae and Shigella causing outbreaks of diarrhoea in the eastern Africa region: 1994-1996. East Afr Med J 1997; 74: 193-7.
77. Tupasi TE. Quinolone use in the developing world. Drugs 1999; 58: 55-9. [CrossRef]
78. Kariuki S, Hart CA. Global aspects of antimicrobial resistant ente- ric bacteria. Curr Opin Infect Dis 2001; 14: 579-86. [CrossRef]
79. Ozmert EN, Göktürk B, Yurdakök K, Yalçin SS, Gür D. Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002. J Pediatr Gastroenterol Nutr 2005; 40: 359-62. [CrossRef]
80. Karacan C, Tavil B, Topal Y, Zorlu P, Tayman C. Evaluation of shigellosis in a Turkish children's hospital. Pediatr Int 2007; 49: 589-92. [CrossRef]
81. Akçali A, Levent B, Akbaş E, Esen B. Typing of Shigella sonnei strains isolated in some provinces of Turkey using antimicrobi- al resistance and pulsed field gel electrophoresis methods. Mikrobiyol Bul 2008; 42: 563-72.
82. Ghosh A, Ramamurthy T. Antimicrobials & cholera: are we stranded? Indian J Med Res 2011; 133: 225-31.
83. Ochoa TJ, Ruiz J, Molina M, et al. High frequency of antimic- robial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am J Trop Med Hyg 2009; 81: 296-301.
84. Cleary TG. Salmonella. In: Feigin RD, Cherry JD, Demmler GJ and Kaplan SL (eds), 5th edition: Textbook of Pediatric Infectious Diseases. Saunders, Philadelphia, 2004, p.1473-87.

APA	Kurugöl Z, devrim i (2014). Gastrointestinal ğnfections. , 71 - 81.
Chicago	Kurugöl Zafer,devrim ilker Gastrointestinal ğnfections. (2014): 71 - 81.
MLA	Kurugöl Zafer,devrim ilker Gastrointestinal ğnfections. , 2014, ss.71 - 81.
AMA	Kurugöl Z,devrim i Gastrointestinal ğnfections. . 2014; 71 - 81.
Vancouver	Kurugöl Z,devrim i Gastrointestinal ğnfections. . 2014; 71 - 81.
IEEE	Kurugöl Z,devrim i "Gastrointestinal ğnfections." , ss.71 - 81, 2014.
ISNAD	Kurugöl, Zafer - devrim, ilker. "Gastrointestinal ğnfections". (2014), 71-81.

APA	Kurugöl Z, devrim i (2014). Gastrointestinal ğnfections. Çocuk Enfeksiyon Dergisi, 8(2), 71 - 81.
Chicago	Kurugöl Zafer,devrim ilker Gastrointestinal ğnfections. Çocuk Enfeksiyon Dergisi 8, no.2 (2014): 71 - 81.
MLA	Kurugöl Zafer,devrim ilker Gastrointestinal ğnfections. Çocuk Enfeksiyon Dergisi, vol.8, no.2, 2014, ss.71 - 81.
AMA	Kurugöl Z,devrim i Gastrointestinal ğnfections. Çocuk Enfeksiyon Dergisi. 2014; 8(2): 71 - 81.
Vancouver	Kurugöl Z,devrim i Gastrointestinal ğnfections. Çocuk Enfeksiyon Dergisi. 2014; 8(2): 71 - 81.
IEEE	Kurugöl Z,devrim i "Gastrointestinal ğnfections." Çocuk Enfeksiyon Dergisi, 8, ss.71 - 81, 2014.
ISNAD	Kurugöl, Zafer - devrim, ilker. "Gastrointestinal ğnfections". Çocuk Enfeksiyon Dergisi 8/2 (2014), 71-81.